Learn More
Medchemexpress LLC Ipatasertib dihydrochloride | 1396257-94-5 | C24H34Cl3N5O2 | 100 MG

Supplier: Medchemexpress LLC HY15186A100MG
Ipatasertib dihydrochloride is a highly selective and ATP-competitive pan-Akt inhibitor. It is provided as a light yellow to yellow solid and is intended for research use only.
- Highly selective and ATP-competitive pan-Akt inhibitor.
- Inhibits Akt1, Akt2, and Akt3 with IC50s of 5, 18, and 8 nM, respectively.
- Demonstrates high selectivity against PKA and p70S6K.
- Efficacious in cell lines and xenograft models with Akt activation.
- Can achieve tumor growth delay, stasis, or regression.
- Enhances tumor growth inhibition in combination therapies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.